Abstract
The aim of this study is to investigate the properties related to peptide inhibitors of replication of Dengue virus type 2, predict whether these compounds exhibit pharmacokinetic properties (absorption, distribution and toxicology) and propose new drug candidates with better properties (physicochemical, toxicological and pharmacokinetic). Fifteen inhibitors of nonstructural protein 3 (NS3) were selected, i.e. the most active in the database of Binding DB, based on the value of Ki. From this study for the development of new potential NS3-protease inhibitor candidates for the Dengue virus type 2 treatments; we described that modifications achieved satisfactory results because three molecules showed improvements in some properties relative to the reference compound, which was the most active. However, the inhibitor that stood out in ADME/Tox calculations among the 15 inhibitors was compound 11, which is better absorbed by oral administration, showing an improvement in the absorption in the intestine, remaining inactive in the central nervous system (CNS). This compound is not carcinogenic for mice in toxicological analysis, yielding a potential drug candidate inhibitor of nonstructural protein 3 (NS3) for Dengue type 2.
Keywords: ADME/Tox, Dengue virus, flavivirus, molecular modeling, NS3 protease inhibitors.
Current Physical Chemistry
Title:Molecular Modeling of Peptide Derivatives NS3 Protease Inhibitors of the Type 2 Dengue Virus
Volume: 6 Issue: 1
Author(s): César F. dos Santos, Anna E. da Silva e Silva, Aline M. Lopes Martins, Carlton A. Taft, Carlos H. T. de Paula da Silva, Cleydson B. R. dos Santos and Lorane I. da Silva Hage- Melim
Affiliation:
Keywords: ADME/Tox, Dengue virus, flavivirus, molecular modeling, NS3 protease inhibitors.
Abstract: The aim of this study is to investigate the properties related to peptide inhibitors of replication of Dengue virus type 2, predict whether these compounds exhibit pharmacokinetic properties (absorption, distribution and toxicology) and propose new drug candidates with better properties (physicochemical, toxicological and pharmacokinetic). Fifteen inhibitors of nonstructural protein 3 (NS3) were selected, i.e. the most active in the database of Binding DB, based on the value of Ki. From this study for the development of new potential NS3-protease inhibitor candidates for the Dengue virus type 2 treatments; we described that modifications achieved satisfactory results because three molecules showed improvements in some properties relative to the reference compound, which was the most active. However, the inhibitor that stood out in ADME/Tox calculations among the 15 inhibitors was compound 11, which is better absorbed by oral administration, showing an improvement in the absorption in the intestine, remaining inactive in the central nervous system (CNS). This compound is not carcinogenic for mice in toxicological analysis, yielding a potential drug candidate inhibitor of nonstructural protein 3 (NS3) for Dengue type 2.
Export Options
About this article
Cite this article as:
dos Santos F. César, da Silva e Silva E. Anna, Lopes Martins M. Aline, Taft A. Carlton, de Paula da Silva H. T. Carlos, dos Santos B. R. Cleydson and da Silva Hage- Melim I. Lorane, Molecular Modeling of Peptide Derivatives NS3 Protease Inhibitors of the Type 2 Dengue Virus, Current Physical Chemistry 2016; 6 (1) . https://dx.doi.org/10.2174/187794680601160324120622
DOI https://dx.doi.org/10.2174/187794680601160324120622 |
Print ISSN 1877-9468 |
Publisher Name Bentham Science Publisher |
Online ISSN 1877-9476 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Differential Involvement of Myosin II and VI in the Spontaneous and SDF- 1-induced Migration of Adult CD133+ Hematopoietic Stem/Progenitor Cells and Leukemic Cells
Current Cancer Therapy Reviews Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor
Current Respiratory Medicine Reviews Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Current Pharmaceutical Design Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
Current Topics in Medicinal Chemistry Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
Anti-Cancer Agents in Medicinal Chemistry Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters Apoptosis Induced by Topoisomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Decreased Parathyroid Hormone Levels Despite Persistent Hypocalcemia in Patients with Kidney Failure Recovering from Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets Modeling of 2-Pyridin-3-yl-Benzo[d][1,3]Oxazin-4-one Derivatives by Several Conformational Searching Tools and Molecular Docking
Current Pharmaceutical Design Optimizing Tumor-Reactive γδT Cells for Antibody-Based Cancer Immunotherapy
Current Molecular Medicine Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Anti-Cancer Agents in Medicinal Chemistry Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry Patent Selections :
Recent Patents on Biomarkers Lectin Techniques for Glycoproteomics
Current Proteomics Natural Products and their Analogues as Efficient Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Current Bioinformatics